These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1282517

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.
    Vermeulen A, Piotrovsky V, Ludwig EA.
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):183-206. PubMed ID: 17136449
    [Abstract] [Full Text] [Related]

  • 28. High-performance of liquid chromatographic determination of [3,4-di-(4-methoxyphenyl)-5-isoxazolyl]acetic acid and its metabolites in human plasma and urine.
    Marunaka T, Maniwa M.
    J Chromatogr; 1987 Nov 27; 422():227-33. PubMed ID: 3501788
    [Abstract] [Full Text] [Related]

  • 29. Analytical and semipreparative enantioseparation of 9-hydroxyrisperidone, the main metabolite of risperidone, using high-performance liquid chromatography and capillary electrophoresis. Validation and determination of enantiomeric purity.
    Danel C, Barthélémy C, Azarzar D, Robert H, Bonte JP, Odou P, Vaccher C.
    J Chromatogr A; 2007 Sep 07; 1163(1-2):228-36. PubMed ID: 17617416
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.
    Gunes A, Spina E, Dahl ML, Scordo MG.
    Ther Drug Monit; 2008 Oct 07; 30(5):628-33. PubMed ID: 18708991
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.
    Jung SM, Kim KA, Cho HK, Jung IG, Park PW, Byun WT, Park JY.
    Clin Pharmacol Ther; 2005 Nov 07; 78(5):520-8. PubMed ID: 16321618
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A water-compatible magnetic molecularly imprinted polymer for the selective extraction of risperidone and 9-hydroxyrisperidone from human urine.
    Ji WH, Guo YS, Wang X, Guo DS.
    Talanta; 2018 May 01; 181():392-400. PubMed ID: 29426531
    [Abstract] [Full Text] [Related]

  • 39. In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone.
    Titier K, Déridet E, Moore N.
    Toxicol Appl Pharmacol; 2002 Apr 15; 180(2):145-9. PubMed ID: 11969382
    [Abstract] [Full Text] [Related]

  • 40. Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone.
    Aravagiri M, Marder SR, Nuechterlein KH, Gitlin MJ.
    Ther Drug Monit; 2003 Dec 15; 25(6):657-64. PubMed ID: 14639051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.